Article
No association of CpG island methylator phenotype and colorectal cancer survival: population-based study.
British journal of cancer - 22 Nov 2016
Jia Min, Jansen Lina, Walter Viola, Tagscherer Katrin, Roth Wilfried, Herpel Esther, Kloor Matthias, Bläker Hendrik, Chang-Claude Jenny, Brenner Hermann, Hoffmeister Michael
Abstract excerpt
BACKGROUND: Previous studies have shown adverse effects of CpG island methylator phenotype (CIMP) on colorectal cancer (CRC) prognosis. However, sample sizes were often limited and only few studies were able to adjust for relevant molecular features associated with CIMP. The aim of this study was to investigate the impact of CIMP on CRC survival in a large population-based study with comprehensive adjustment....
Topics
- Aged
- Antineoplastic Agents
- Colorectal Neoplasms
- CpG Islands
- DNA Methylation
- Female
- Humans
- Male
- Middle Aged
- Phenotype
- Survival Analysis
